Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Return on Sales (2016 - 2025)

OptimizeRx's Return on Sales history spans 16 years, with the latest figure at 0.03% for Q3 2025.

  • For Q3 2025, Return on Sales rose 46.0% year-over-year to 0.03%; the TTM value through Sep 2025 reached 0.04%, up 40.0%, while the annual FY2024 figure was 0.17%, 8.0% up from the prior year.
  • Return on Sales for Q3 2025 was 0.03% at OptimizeRx, down from 0.05% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.15% in Q4 2024 and bottomed at 0.49% in Q1 2023.
  • The 5-year median for Return on Sales is 0.18% (2023), against an average of 0.16%.
  • The largest annual shift saw Return on Sales plummeted -40bps in 2023 before it surged 56bps in 2024.
  • A 5-year view of Return on Sales shows it stood at 0.03% in 2021, then crashed by -154bps to 0.02% in 2022, then tumbled by -2396bps to 0.41% in 2023, then surged by 135bps to 0.15% in 2024, then crashed by -80bps to 0.03% in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Return on Sales are 0.03% (Q3 2025), 0.05% (Q2 2025), and 0.1% (Q1 2025).